Percutaneous heart valve implantation in congenital and degenerative valve disease. A rapid Health Technology Assessment.

This Health Technology Assessment report summarises current evidence supporting the use of percutaneous heart valves in degenerative aortic valve and congenital pulmonary outflow tract disease, as compared to conservative medical therapy or traditional surgical valve replacement. Percutaneous aortic valve insertion has been reported since 2002 for the treatment of calcific aortic valve stenosis in elderly patients considered to be at unacceptably high risk for conventional surgery. Percutaneous pulmonary valve insertion has been first reported in the year 2000. The procedure is restricted to patients with congenital heart disease in whom degeneration of a previously surgically reconstructed right ventricular outflow tract has occurred.

Tags: implantable, valve
Year: 2008